Business Context and Reporting Period
Company: Benchmark Electronics, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2003
Business Overview: Benchmark provides electronics manufacturing services (EMS) to original equipment manufacturers (OEMs) across various sectors including computers, medical devices, and telecommunications. The company operates 15 manufacturing facilities in the Americas, Europe, and Asia. A significant portion of the current period's results reflects the integration of facilities acquired from ACT Manufacturing in July 2002 (UK and Thailand).
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2003 | Q1 2002 |
|---|---|---|
| Sales | $448,470 | $329,188 |
| Gross Profit | $35,605 | $24,875 |
| Gross Margin | 7.9% | 7.6% |
| Income from Operations | $27,241 | $10,699 |
| Net Income | $17,331 | $5,348 |
| Diluted EPS | $0.66 | $0.26 |
| Cash from Operations | $13,754 | $26,037 |
| Cash and Equivalents (End of Period) | $322,023 | $79,940 |
| Total Debt (Current + Long-term) | $129,807 | N/A |
Note: Total Debt calculated as Current installments of long-term debt ($29,518) + Convertible subordinated notes ($80,200) + Other long-term debt ($20,089).
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 36.2% year-over-year. This growth was driven by the inclusion of acquired UK and Thailand operations (46.8% of the increase), expansion of systems integration facilities (30.8%), and a 24.4% net increase in sales volumes.
- Profitability: Net income surged 224% to $17.3 million. A significant non-cash gain of $8.1 million from a contract settlement contributed to operating income.
- Operating Cash Flow: Cash provided by operating activities decreased 47% to $13.8 million, primarily due to a $16.6 million increase in accounts receivable and a $14.5 million decrease in accrued liabilities, despite improvements in inventory management.
- Segment Performance:
- Americas: Sales increased $44.5 million; Operating income rose to $31.8 million.
- Europe: Sales increased $24.4 million; Operating income turned negative at $(2.5) million compared to $1.9 million profit in 2002.
- Asia: Sales increased $50.3 million (driven by the Thailand acquisition); Operating income improved to $1.8 million from a loss of $0.1 million.
Guidance, Outlook, and Risks
Management Commentary:
- Outlook: Management expects gross margins to fluctuate based on facility utilization, product mix, and the general slowdown in technology markets. High-volume programs in price-sensitive markets may exert downward pressure on margins.
- Liquidity: The company maintains a $175 million revolving credit facility with $174.6 million available. Management believes existing cash and credit facilities are sufficient for liquidity requirements.
- Debt: The company repaid $11.1 million of its Thai Credit Agreement on April 1, 2003 (subsequent to the period end). The debt-to-total capitalization ratio was 20% as of March 31, 2003.
Risks and Contingencies:
- Customer Concentration: The two largest customers represented 59.4% of sales in Q1 2003, with one customer exceeding 40%. Loss of a major customer would have a material adverse effect.
- Legal Proceedings:
- AVEX Acquisition Dispute: Ongoing litigation with J.M. Huber Corporation regarding the 1999 acquisition of AVEX. Oral arguments were presented to the Fifth Circuit in March 2003.
- Patent Infringement: Named as a defendant in a lawsuit by the Lemelson Foundation regarding machine vision patents. The case is stayed pending a decision in a related Symbol/Cognex case expected in 2003.
- Inventory Risk: Recorded $4.0 million in inventory reserves for excess and obsolete inventory in Q1 2003. The company bears the risk of component price increases and shortages.
Investor Verification Checklist
- Contract Settlement Gain: Verify the sustainability of the $8.1 million non-cash gain included in operating income, as this is a one-time item.
- Customer Concentration: Assess the stability of the top two customers, who account for nearly 60% of revenue.
- Accounts Receivable: Review the $16.6 million increase in receivables and the adequacy of the $8.0 million allowance for doubtful accounts.
- Legal Exposure: Monitor the status of the AVEX acquisition appeal and the Lemelson patent infringement stay.
- Inventory Reserves: Evaluate the $19.2 million total inventory obsolescence reserve against future demand forecasts.